Mitchell Sinkler & Starr’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Buy |
+2,360
| New | +$206K | 0.1% | 141 |
|
|
2025
Q1 | – | Sell |
-2,838
| Closed | -$221K | – | 157 |
|
|
2024
Q4 | $221K | Buy |
+2,838
| New | +$221K | 0.06% | 152 |
|
|
2024
Q3 | – | Sell |
-2,838
| Closed | -$314K | – | 190 |
|
|
2024
Q2 | $314K | Buy |
2,838
+1,200
| +73% | +$133K | 0.08% | 120 |
|
|
2024
Q1 | $227K | Sell |
1,638
-6,872
| -81% | -$953K | 0.06% | 152 |
|
|
2023
Q4 | $1.06M | Buy |
8,510
+1,920
| +29% | +$238K | 0.19% | 93 |
|
|
2023
Q3 | $615K | Buy |
6,590
+3,780
| +135% | +$353K | 0.19% | 74 |
|
|
2023
Q2 | $361K | Hold |
2,810
| – | – | 0.1% | 112 |
|
|
2023
Q1 | $326K | Buy |
2,810
+272
| +11% | +$31.6K | 0.1% | 116 |
|
|
2022
Q4 | $287K | Buy |
+2,538
| New | +$287K | 0.09% | 121 |
|
|
2022
Q2 | – | Sell |
-1,708
| Closed | -$218K | – | 115 |
|
|
2022
Q1 | $218K | Hold |
1,708
| – | – | 0.07% | 117 |
|
|
2021
Q4 | $229K | Hold |
1,708
| – | – | 0.07% | 116 |
|
|
2021
Q3 | $234K | Buy |
+1,708
| New | +$234K | 0.21% | 98 |
|